Cargando…
Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date
Atopic dermatitis is a prevalent, inflammatory skin disease that presents with an eczematous, itchy rash. As of late, there have been many emerging monoclonal antibody inhibitor and small molecule therapies that have changed the course of eczema treatment. One of the treatments in the pipeline for a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188775/ https://www.ncbi.nlm.nih.gov/pubmed/35702658 http://dx.doi.org/10.2147/CCID.S295672 |